• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病足溃疡患者血浆凝血酶激活的纤溶抑制物(TAFI)抗原水平。

Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers.

机构信息

Department of Endocrinology and Metabolism Disease, Ege University Medical School, Bornova, 35100 Izmir, Turkey.

出版信息

Endocrine. 2010 Jun;37(3):449-54. doi: 10.1007/s12020-010-9329-1. Epub 2010 Apr 14.

DOI:10.1007/s12020-010-9329-1
PMID:20960167
Abstract

Plasma TAFI may participate in arterial thrombosis in cardiovascular diseases (CVD) and may be involved in the mechanism of vascular endothelial damage in diabetic patients. The aim of this study was to investigate the association of plasma TAFI antigen level in the development of diabetic foot ulcer in Type 2 diabetes. The TAFI antigen levels were determined in 50 patients with diabetic foot ulcers and 34 patients without diabetic foot ulcers and 25 healthy individuals. We measured TAFIa/ai antigen in plasma samples with a commercially available ELISA Kit. Diabetic foot ulcer group and diabetic group were similar in terms of mean age and sex distribution. Diabetes duration, retinopathy, neuropathy, macrovascular disease and infection were related to diabetic foot ulcers. HbA1c, HDL-cholesterol and Folic Acid levels were decreased in the diabetic foot ulcer group. TAFI levels were 99.44 ± 55.94% in control group, 135.21 ± 61.05% in diabetic foot ulcer group, 136.75 ± 59.38% in diabetic group and was statistically different (P < 0.05). But no difference was seen in TAFI levels between the diabetic foot ulcer group and diabetic group (P > 0.05). No significant difference in plasma TAFI levels were seen between diabetic foot ulcer stages. TAFI antigen levels are increased in Type 2 diabetic patients, but are not related to diabetic foot ulcer development.

摘要

血浆 TAFI 可能参与心血管疾病 (CVD) 中的动脉血栓形成,并且可能与糖尿病患者血管内皮损伤的机制有关。本研究旨在探讨 2 型糖尿病患者血浆 TAFI 抗原水平在糖尿病足溃疡发展中的相关性。测定了 50 例糖尿病足溃疡患者、34 例无糖尿病足溃疡患者和 25 例健康个体的血浆 TAFI 抗原水平。我们使用市售的 ELISA 试剂盒测定血浆中 TAFIa/ai 抗原。糖尿病足溃疡组和糖尿病组在年龄和性别分布方面相似。糖尿病病程、视网膜病变、神经病变、大血管疾病和感染与糖尿病足溃疡有关。糖尿病足溃疡组的 HbA1c、HDL-胆固醇和叶酸水平降低。对照组 TAFI 水平为 99.44 ± 55.94%,糖尿病足溃疡组为 135.21 ± 61.05%,糖尿病组为 136.75 ± 59.38%,差异有统计学意义 (P < 0.05)。但糖尿病足溃疡组与糖尿病组之间 TAFI 水平无差异 (P > 0.05)。糖尿病足溃疡各期之间 TAFI 水平无显著差异。2 型糖尿病患者血浆 TAFI 抗原水平升高,但与糖尿病足溃疡的发生无关。

相似文献

1
Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers.糖尿病足溃疡患者血浆凝血酶激活的纤溶抑制物(TAFI)抗原水平。
Endocrine. 2010 Jun;37(3):449-54. doi: 10.1007/s12020-010-9329-1. Epub 2010 Apr 14.
2
Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission.肢端肥大症缓解患者的血浆凝血酶激活的纤溶抑制物(TAFI)抗原水平。
Turk J Med Sci. 2019 Oct 24;49(5):1381-1385. doi: 10.3906/sag-1812-231.
3
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.因因子V莱顿突变导致活化蛋白C抵抗的患者中凝血酶可激活纤溶抑制物抗原及TAFI活性
Thromb Res. 2002 Apr 1;106(1):59-62. doi: 10.1016/s0049-3848(02)00072-5.
4
Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.血压正常的微量白蛋白尿2型糖尿病患者血浆凝血酶激活的纤溶抑制物水平升高。
J Clin Endocrinol Metab. 2003 Feb;88(2):736-41. doi: 10.1210/jc.2002-020691.
5
Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.人腹主动脉瘤疾病中的凝血酶激活的纤溶抑制物。
J Thromb Haemost. 2017 Nov;15(11):2218-2225. doi: 10.1111/jth.13804. Epub 2017 Sep 25.
6
Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).凝血酶激活的纤溶抑制物(TAFI)-抗磷脂综合征(APS)中凝血与补体激活的可能联系。
Thromb Res. 2017 Oct;158:168-173. doi: 10.1016/j.thromres.2017.06.028. Epub 2017 Jun 24.
7
Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.左甲状腺素替代治疗可降低显性和亚临床甲状腺功能减退患者中升高的凝血酶激活的纤溶抑制物(TAFI)抗原水平。
Endocr J. 2007 Feb;54(1):45-52. doi: 10.1507/endocrj.k06-062. Epub 2006 Nov 8.
8
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications.凝血酶激活的纤溶抑制物与有无微血管并发症的I型糖尿病患者的止血变化
Blood Coagul Fibrinolysis. 2003 Sep;14(6):551-6. doi: 10.1097/00001721-200309000-00006.
9
Thrombin activatable fibrinolysis inhibitor (TAFI) in cord blood.脐带血中的凝血酶激活的纤溶抑制物(TAFI)
Folia Histochem Cytobiol. 2007;45(1):33-6.
10
[Thrombin activatable fibrinolysis o inhibitor-TAFI- in dialyzed patients with diabetic nephropathy].[糖尿病肾病透析患者中的凝血酶激活的纤维蛋白溶解抑制物 - TAFI -]
Pol Arch Med Wewn. 2003 Aug;110(2):843-8.

引用本文的文献

1
Clinical Outcomes of Hyperbaric Oxygen Therapy for Diabetic Foot Ulcers: A Systematic Review.高压氧治疗糖尿病足溃疡的临床结局:一项系统评价
Cureus. 2025 Feb 6;17(2):e78655. doi: 10.7759/cureus.78655. eCollection 2025 Feb.
2
Association between Lipid Profile and Apolipoproteins with Risk of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.血脂谱和载脂蛋白与糖尿病足溃疡风险的关系:系统评价和荟萃分析。
Int J Clin Pract. 2022 Aug 10;2022:5450173. doi: 10.1155/2022/5450173. eCollection 2022.
3
A Retrospective Analysis of the Relationship Between 25-OH-Vitamin D and Diabetic Foot Ulcer.

本文引用的文献

1
[Diabetic foot: detection and prevention].[糖尿病足:检测与预防]
Rev Med Interne. 2008 Sep;29 Suppl 2:S260-3. doi: 10.1016/S0248-8663(08)73954-7.
2
[Peripheral vascular disease and diabetic foot].[外周血管疾病与糖尿病足]
Rev Med Interne. 2008 Sep;29 Suppl 2:S249-59. doi: 10.1016/S0248-8663(08)73953-5.
3
[Infection and diabetic foot].[感染与糖尿病足]
25-羟基维生素D与糖尿病足溃疡关系的回顾性分析
Diabetes Metab Syndr Obes. 2022 May 3;15:1347-1355. doi: 10.2147/DMSO.S358170. eCollection 2022.
4
Association Between Serum 25-OH-Vitamin D and Diabetic Foot Ulcer in Patients With Type 2 Diabetes.2型糖尿病患者血清25-羟基维生素D与糖尿病足溃疡之间的关联
Front Nutr. 2020 Sep 2;7:109. doi: 10.3389/fnut.2020.00109. eCollection 2020.
5
Thrombin activatable fibrinolysis inhibitor as an indicator of the severity of acute pancreatitis.凝血酶激活的纤溶抑制物作为急性胰腺炎严重程度的指标。
Turk J Gastroenterol. 2018 Jul;29(4):488-493. doi: 10.5152/tjg.2018.17666.
6
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.脂蛋白(a)和同型半胱氨酸作为 2 型糖尿病血管性和神经性糖尿病足的遗传危险因素。
Endocrine. 2012 Feb;41(1):89-95. doi: 10.1007/s12020-011-9544-4. Epub 2011 Oct 11.
Rev Med Interne. 2008 Sep;29 Suppl 2:S243-8. doi: 10.1016/S0248-8663(08)73952-3.
4
[Physiopathology of the diabetic foot].[糖尿病足的病理生理学]
Rev Med Interne. 2008 Sep;29 Suppl 2:S231-7. doi: 10.1016/S0248-8663(08)73950-X.
5
[Epidemiology of diabetic foot problems].[糖尿病足问题的流行病学]
Rev Med Interne. 2008 Sep;29 Suppl 2:S222-30. doi: 10.1016/S0248-8663(08)73949-3.
6
Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.疾病机制:糖尿病神经病变的氧化应激理论
Rev Endocr Metab Disord. 2008 Dec;9(4):301-14. doi: 10.1007/s11154-008-9104-2.
7
Diabetic foot infection.糖尿病足感染
Am Fam Physician. 2008 Jul 1;78(1):71-9.
8
The biology of chronic foot ulcers in persons with diabetes.糖尿病患者慢性足部溃疡的生物学特性
Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S25-30. doi: 10.1002/dmrr.847.
9
Multidisciplinary management of the diabetic foot ulcer.糖尿病足溃疡的多学科管理
Br J Community Nurs. 2007 Dec;12(12):S6, S8, S10 passim.
10
The diabetic foot.糖尿病足
QJM. 2008 Sep;101(9):685-95. doi: 10.1093/qjmed/hcn027. Epub 2008 Mar 18.